If your seizures have always related to your cycle, perimenopause is likely to be an unsettled period — and the interactions between anti-seizure medication and hormone therapy are real, specific, and rarely explained. This is one of the least covered intersections in menopause care, and it is one where the details matter.
Where we stand: Menova is an independent publication. We sell no hormones and no medication, we are not your doctor, and this is general education, not medical advice. Never change anti-seizure medication doses on your own. Everything here belongs with your neurologist.
Catamenial epilepsy, and why perimenopause disturbs it
Some women have seizures that cluster at particular points in the menstrual cycle — a pattern called catamenial epilepsy. The working explanation involves the differing effects of estrogen and progesterone on neuronal excitability: estrogen is generally regarded as proconvulsant and progesterone as anticonvulsant, so the ratio between them matters more than either level alone.
In perimenopause that ratio becomes erratic. Cycles without ovulation produce no progesterone while estrogen continues — and can spike higher than before. For women with a cycle-linked pattern, that combination frequently makes seizure frequency less predictable during the transition.
The reported picture afterward is more encouraging: many women with catamenial epilepsy find seizure frequency settles or improves after menopause, when hormone levels are low and stable. Perimenopause is the difficult stretch, not the permanent state.
The medication interaction that matters most
Enzyme-inducing anti-seizure medications — carbamazepine, phenytoin, phenobarbital, primidone, and topiramate at higher doses among others — increase the liver metabolism of estrogen. That has two consequences:
- Hormone therapy may be less effective at standard doses, and a higher dose or a non-oral route may be needed
- Hormonal contraception can be less reliable, which matters while you still need contraception in perimenopause; see which contraception in perimenopause
And the reverse direction: estrogen can affect the levels of some anti-seizure medications — lamotrigine is the well-documented example, where estrogen-containing preparations can substantially lower lamotrigine levels and starting or stopping them may require a dose review.
Neither of these means you cannot have hormone therapy. They mean the two prescribers need to be talking to each other, and that levels may need checking around any change. Say explicitly to each: "I'm on the other treatment — does this need adjusting?" See medications and menopause interactions.
Which route and regimen
Points worth raising with a neurologist and a menopause clinician together:
- Transdermal estrogen avoids first-pass liver metabolism, which is relevant when enzyme induction is the concern — and is generally preferred anyway on clot risk; see HRT and blood clot risk and HRT types and forms
- Continuous rather than cyclical regimens are sometimes preferred where seizures track hormonal fluctuation, since the aim is steadiness rather than a monthly rise and fall
- Steadiness is the principle throughout. What provokes seizures in this context is change, so gradual adjustments and avoiding gaps in supply both matter
Bone: the issue that gets missed
This is the part most likely to go unmanaged, and it compounds.
Several anti-seizure medications are associated with reduced bone density, particularly enzyme-inducing ones and valproate, through effects on vitamin D metabolism and bone turnover. Bone loss also accelerates around menopause. People with epilepsy additionally have a higher fracture risk from seizure-related falls.
Three factors pointing the same way is a strong case for acting rather than waiting:
- Ask about a bone density scan, and about vitamin D testing
- Resistance and impact exercise, the only intervention that builds bone; see bone health in menopause and vitamin D and calcium
- Review whether your medication regimen is still the right one for a person now also facing menopausal bone loss — a legitimate question, not a challenge to your neurologist
Sleep, and why it matters more here
Sleep deprivation is one of the most consistent seizure triggers, and menopausal night sweats and insomnia are close to universal in the transition.
That makes treating sleep a seizure-management issue rather than a comfort one. If night sweats are waking you repeatedly, that is worth raising with both clinicians — see perimenopause sleep problems and night sweats in perimenopause.
One caution: some medications used for menopausal symptoms interact with anti-seizure drugs or affect seizure threshold. Check anything new — including over-the-counter sleep aids and supplements — with your neurologist or pharmacist rather than assuming a non-prescription product is neutral.
Distinguishing symptoms
Two overlaps worth naming:
- Auras and vasomotor symptoms can both involve a rising sensation, flushing, and a sense of something imminent. If you cannot tell them apart, that is worth describing precisely rather than assuming
- Cognitive change is common both in the menopause transition and as a medication effect; brain fog attributed to hormones may be worth reviewing against your regimen. See why brain fog happens
What to bring to the appointment
The record that helps most here is a seizure diary alongside a cycle and symptom record — the relationship between them is exactly what a neurologist needs to decide whether hormonal change is driving a pattern.
Note: seizure dates and type, cycle dates or absence of them, sleep, night sweats, and any missed doses. Our free 30-day symptom tracker works alongside a seizure diary, and the free printable visit prep sheet gives you one page covering both.
The question worth asking:
"My seizure pattern has changed alongside my cycle changing. Could perimenopause be involved — and if I consider hormone therapy, how would it interact with my medication? Also, given my medication and my age, should I have a bone density scan?"
That covers the three things that actually matter here in one sentence each. The free 2-minute self-check organizes the menopausal side — no account, not a diagnosis, and your answers never leave your device.
This article is general education, not medical advice. Epilepsy management requires a neurologist, and hormone therapy decisions here need both specialists involved. Never change anti-seizure medication on your own, and seek urgent care for prolonged or clustered seizures.
Sources: NINDS — Epilepsy and Seizures, Epilepsy Foundation — Women and Epilepsy, NICE NG217 — Epilepsies in Adults, and The Menopause Society.